Potomac, MD, United States of America

Charles E Birse


Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 117(Granted Patents)


Location History:

  • Potomac, MD (US) (2005)
  • North Potomac, MD (US) (2003 - 2014)
  • Danville, CA (US) (2019 - 2021)

Company Filing History:


Years Active: 2003-2021

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Journey of Charles E. Birse

Introduction

Charles E. Birse, an accomplished inventor based in Potomac, MD, has made significant contributions to the scientific community through his innovative research and developments. With a portfolio of 11 patents, his work primarily focuses on advancements in medical diagnostics and treatment, particularly relating to cancer.

Latest Patents

Among his latest patents is a remarkable development involving lung cancer markers and their multiple uses. This patented technology provides methods and compositions for assessing, diagnosing, treating, and preventing diseases, with a specific emphasis on lung cancer. The invention includes individual lung cancer markers (LCM) and panels that can be utilized for various applications. It offers innovative methods for determining treatment effectiveness and for selecting appropriate treatment options using LCM. Additionally, his work provides compositions that modulate cell function through LCM, including antagonists and agonists like antibodies, proteins, small molecules, and nucleic acid agents. His inventions also feature methods of screening for agents that can affect LCM, contributing to the advancement of lung cancer therapies.

Career Highlights

Charles E. Birse has had a notable career, collaborating with esteemed organizations such as Celera Corporation and Human Genome Sciences, Inc. His work has been instrumental in the field of genomics, pushing the boundaries of what is possible in the diagnosis and treatment of cancer.

Collaborations

Throughout his career, Birse has worked alongside distinguished colleagues, including Steve Ruben and Mehdi Mesri. These collaborations have further enriched his research output and helped propel his innovations to greater heights.

Conclusion

In summary, Charles E. Birse is a prominent figure in the realm of medical innovation, particularly in lung cancer research. His extensive patent portfolio and collaborative efforts underscore his commitment to advancing healthcare solutions for the benefit of patients worldwide. As the field continues to evolve, Birse's contributions will undoubtedly play a vital role in shaping the future of cancer diagnostics and therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…